Natural Capsules Limited Shareholders Approve Enhancement of Investment Limits
Natural Capsules Limited successfully concluded its postal ballot process on March 27, 2026, with shareholders providing exceptional support (99.99% approval) for enhancing limits on investments, loans, guarantees, and securities under Section 186 of the Companies Act, 2013. The e-voting process saw participation from 47 voting members representing 50.99% of outstanding shares, with results declared on March 30, 2026, following proper regulatory compliance and scrutinizer oversight.

*this image is generated using AI for illustrative purposes only.
Natural Capsules Limited has successfully concluded its postal ballot process, with shareholders providing overwhelming support for the company's proposal to enhance limits for investments, loans, guarantees, and securities under Section 186 of the Companies Act, 2013. The voting results were declared on March 30, 2026, following the completion of the remote e-voting period that ended on March 27, 2026.
Voting Results and Participation
The special resolution received exceptional shareholder support, with detailed voting statistics demonstrating strong confidence in the company's strategic direction:
| Voting Category: | Votes in Favour | Votes Against | Total Votes | Approval Rate |
|---|---|---|---|---|
| Combined Result: | 5,296,294 | 201 | 5,296,495 | 99.99% |
| Promoter Group: | 5,280,703 | 0 | 5,280,703 | 100.00% |
| Public Non-Institutions: | 15,591 | 201 | 15,792 | 98.73% |
Shareholder Participation Details
The postal ballot process witnessed participation from various shareholder categories, with comprehensive voting statistics recorded:
| Participation Metrics: | Details |
|---|---|
| Total Shareholders (Record Date): | 9,216 |
| Record Date: | February 20, 2026 |
| Voting Members: | 47 |
| Outstanding Shares Voted: | 50.99% |
| Total Shares Outstanding: | 10,386,154 |
E-Voting Process and Timeline
The company conducted the postal ballot through a remote e-voting system, ensuring transparent and accessible participation for all eligible shareholders. The voting process was structured with specific timelines and regulatory compliance:
| Process Timeline: | Date/Time |
|---|---|
| Voting Period: | February 26, 2026 (09:00 AM IST) to March 27, 2026 (05:00 PM IST) |
| Notice Date: | February 13, 2026 |
| Notice Distribution: | February 24, 2026 |
| Scrutinizer Report: | March 28, 2026 |
| Results Declaration: | March 30, 2026 |
Resolution Details and Regulatory Compliance
The approved special resolution pertains to the enhancement of limits for investments, loans, guarantees, and securities under Section 186 of the Companies Act, 2013. This approval provides the company with increased financial flexibility for strategic investments and business expansion activities.
Scrutinizer Oversight: Deepak Sadhu, a practicing Company Secretary (Membership No. 39541), served as the appointed scrutinizer for the postal ballot process. The scrutinizer ensured compliance with Section 108 and Section 110 of the Companies Act, 2013, along with relevant SEBI regulations.
Corporate Governance and Transparency
The postal ballot process demonstrated strong corporate governance practices, with the company adhering to all regulatory requirements under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The resolution was deemed passed on March 27, 2026, being the last date for remote e-voting, and the results were promptly communicated to BSE Limited and National Stock Exchange of India Limited as per regulatory obligations under Regulation 44(3).
Historical Stock Returns for Natural Capsules
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +9.19% | +10.00% | +11.03% | -27.87% | -24.29% | -33.88% |
What specific investment opportunities or acquisitions is Natural Capsules targeting with these enhanced financial limits?
How will the increased investment capacity under Section 186 impact Natural Capsules' competitive position in the pharmaceutical capsules market?
What timeline has management set for deploying the additional investment, loan, and guarantee capabilities approved by shareholders?

































